Savara, Inc. (SVRA)
5.34
+0.08
(+1.52%)
USD |
NASDAQ |
Aug 31, 13:28
Savara Cash and Short Term Investments (Quarterly) : 173.03M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 173.03M |
| March 31, 2026 | 202.77M |
| December 31, 2025 | 235.70M |
| September 30, 2025 | 124.39M |
| June 30, 2025 | 146.44M |
| March 31, 2025 | 172.50M |
| December 31, 2024 | 196.33M |
| September 30, 2024 | 219.44M |
| June 30, 2024 | 121.52M |
| March 31, 2024 | 143.04M |
| December 31, 2023 | 162.32M |
| September 30, 2023 | 168.25M |
| June 30, 2023 | 105.18M |
| March 31, 2023 | 114.78M |
| December 31, 2022 | 125.88M |
| September 30, 2022 | 134.08M |
| June 30, 2022 | 142.44M |
| March 31, 2022 | 151.80M |
| December 31, 2021 | 161.17M |
| September 30, 2021 | 170.81M |
| June 30, 2021 | 180.67M |
| March 31, 2021 | 192.71M |
| December 31, 2020 | 82.19M |
| September 30, 2020 | 94.34M |
| June 30, 2020 | 99.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 104.99M |
| December 31, 2019 | 121.77M |
| September 30, 2019 | 106.28M |
| June 30, 2019 | 111.73M |
| March 31, 2019 | 105.18M |
| December 31, 2018 | 110.83M |
| September 30, 2018 | 112.05M |
| June 30, 2018 | 74.76M |
| March 31, 2018 | 84.98M |
| December 31, 2017 | 94.35M |
| September 30, 2017 | 53.29M |
| June 30, 2017 | 61.13M |
| March 31, 2017 | 7.771M |
| December 31, 2016 | 13.37M |
| September 30, 2016 | 26.95M |
| June 30, 2016 | 35.07M |
| March 31, 2016 | 37.09M |
| December 31, 2015 | 40.98M |
| September 30, 2015 | 49.91M |
| June 30, 2015 | 43.38M |
| March 31, 2015 | 49.89M |
| December 31, 2014 | 57.29M |
| September 30, 2014 | 43.07M |
| June 30, 2014 | 46.44M |
| March 31, 2014 | 49.62M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.882B |
| Insmed, Inc. | 1.160B |
| United Therapeutics Corp. | 2.662B |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| SELLAS Life Sciences Group, Inc. | 138.44M |